Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0423 per EA under NDC 29300047716. Its NADAC has been published 117 times since May 29, 2024.
FDA first approved this application on Nov 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300047716
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210907FDA Approved
11/14/2019
TE Code
AB
On Market Since
10/17/2023
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 117 times since May 29, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0509 (Nov 13, 2024) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0466 |
| Average price | $0.0455 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | May 29, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0423 per EA (NDC 29300047716), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 117 weekly CMS publications since May 29, 2024.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since May 29, 2024, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0509 (Nov 13, 2024), with a median of $0.0466 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 29300047716) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.